Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Form 8 (OPD)

March 14, 2024
RNS Number : 9103G Renalytix PLC 14 March 2024       Renalytix plc   (" Renalytix plc " or the "Company")     The following correction has been made to the "FORM 8 (OPD)", which was released on 8 March 2024 at 12:14am   UK time under RNS no. 1928G.       FORM 8 (OPD)   PUBLIC OPENING POSITION

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 14, 2024
RNS Number : 8871G Stifel Nicolaus Europe Limited 14 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

KidneyIntelX™ included in KDIGO 2024 Guideline

March 14, 2024
RNS Number : 7837G Renalytix PLC 14 March 2024       THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF MAR. THE PERSON RESPONSIBLE FOR ARRANGING THE RELEASE OF THIS ANNOUNCEMENT ON BEHALF OF RENALYTIX IS JAMES MCCULLOUGH , CEO.   Renalytix plc ("Renalytix" or the "Company")  

Form 8.3 - Renalytix Plc

March 13, 2024
FORM 8.3 AMENDMENT FOR DISCLOSURE PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.           KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b)

Polar Capital Hldgs - Form 8.3 - RENALYTIX PLC

March 13, 2024
RNS Number : 7712G Polar Capital Holdings PLC 13 March 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of

Form 8.3 - Renalytix Plc

March 13, 2024
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.           KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 13, 2024
RNS Number : 6757G Stifel Nicolaus Europe Limited 13 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Successful completion of upsized $12m placing

March 12, 2024
RNS Number : 5748G Renalytix PLC 12 March 2024     NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ,  CANADA ,  AUSTRALIA , JAPAN , THE REPUBLIC OF SOUTH AFRICA , NEW ZEALAND OR IN OR INTO ANY OTHER JURISDICTION IN WHICH OFFERS

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 12, 2024
RNS Number : 5012G Stifel Nicolaus Europe Limited 12 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name
Displaying 41 - 50 of 347